Mass. shuts 11 pharmacies following inspections (Update)

February 5, 2013 by Steve Leblanc

(AP)—Massachusetts officials have ordered 11 pharmacies to completely or partially shut down after a series of inspections prompted by a deadly fungal meningitis outbreak.

The outbreak was discovered in Tennessee in September and has killed 45 people and sickened more than 600 nationwide. It was caused by drugs linked to the Framingham-based New England Compounding Center, which produced a contaminated steroid and has since closed.

The unannounced inspections were conducted over the past several months at 40 Massachusetts sterile compounding pharmacies, which custom-mix medications in doses or forms generally not commercially available.

Besides the 11 cease-and-desist orders, public health inspectors cited 21 other pharmacies for minor deficiencies that have since been corrected or are being addressed.

Pharmacies that have been shut down must submit plans and take corrective actions before they can begin producing drugs again.

Explore further: Mass. Gov. proposes new compounding pharmacy rules

shares

Related Stories

Mass. Gov. proposes new compounding pharmacy rules

January 4, 2013
(AP)—Gov. Deval Patrick is proposing tighter regulations on compounding pharmacies following last year's deadly meningitis outbreak linked to a Massachusetts company.

Senate questions pharmacy boards after outbreak

November 19, 2012
(AP)—A Senate committee investigating a deadly outbreak of meningitis wants to know how regulators in all 50 states oversee specialty pharmacies like the one that triggered the illness.

FDA chief renews push for specialty pharmacy rules

December 19, 2012
(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest ...

Congress investigating compounding trade group

December 7, 2012
(AP)—House lawmakers are investigating whether the industry group for compounding pharmacies coached the company responsible for a deadly outbreak of meningitis in dealing with regulators.

Consumer watchdog asks FDA to revisit compounders

November 29, 2012
(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...

FDA chief seeks new powers to police pharmacies

November 14, 2012
(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.